>> Continued From the Previous Page <<
Despite Trump’s words, the reaction from the crowd was clear: conservatives have not forgotten Pfizer’s role in pushing COVID-19 vaccines. The backlash highlights an ongoing divide in the GOP, where vaccine skepticism has become a dominant sentiment.
A Complicated Relationship With Big Pharma
Trump has walked a fine line when it comes to pharmaceutical companies. On one hand, he championed Operation Warp Speed, pouring billions into accelerating vaccine development. On the other, he knows that his base is deeply critical of the industry. Many see vaccine mandates and pharmaceutical lobbying as a threat to personal freedoms, making Pfizer a symbol of government overreach.
The tension between grassroots conservatives and Big Pharma recently flared up during the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services (HHS). Many Trump supporters hailed RFK Jr. as a champion of medical freedom, while pharmaceutical executives and mainstream health organizations remained skeptical or silent.
Vaccine Skepticism Surges Among Republicans
Doubts about vaccines have grown significantly since the COVID-19 pandemic. Even in deep-blue states like Massachusetts, vaccine uptake has declined. According to Newsweek, as of January 2025, about one in four Republican parents admit to delaying or skipping vaccines for their children.
This skepticism isn’t just about COVID-19. Many conservatives now question the entire vaccine industry, a major shift from pre-pandemic attitudes. The negative reception toward Bourla is just the latest sign of this growing mistrust.
WATCH:
Backlash Against the Health Industry Intensifies
Adding fuel to the fire is the recent murder of UnitedHealthcare CEO Brian Thompson. His assassination by a lone gunman sparked widespread public anger against the health insurance industry. Shockingly, bipartisan outrage quickly turned into sympathy for the shooter, as Americans vented frustration over skyrocketing premiums and bureaucratic control over their healthcare.
The hostility toward insurance giants and pharmaceutical companies has put politicians in a tough spot. While some remain hesitant to criticize major donors, others see an opportunity to align with the growing anti-establishment sentiment sweeping across the country.
Bourla Tries to Mend Fences
Despite the boos, Bourla has been working behind the scenes to repair his standing. In December, he met privately with RFK Jr., weeks before Kennedy’s nomination to lead HHS. Since then, Kennedy has made several remarks indicating a possible softening of his stance toward vaccine makers.
Meanwhile, Trump has touted the development of artificial intelligence to advance medical research. The $100 billion Stargate initiative, backed by OpenAI, SoftBank, and Oracle, aims to revolutionize mRNA technology—the same technology used in Pfizer’s COVID-19 vaccine. While Trump supports innovation, he remains cautious not to alienate his base, which remains highly skeptical of Big Pharma.
KICK OUT The Cold and Say Hello to The Handyheater! Warming Any Spot INSTANTLY!
Trump Knows His Base Isn’t Buying It
Trump himself has faced criticism for his early support of COVID-19 vaccines. In December 2021, he was booed after revealing he had been vaccinated while on stage with Bill O’Reilly. Since then, he has largely avoided the topic, knowing full well that many of his supporters remain firmly opposed.
The reaction at the White House event makes it clear: Pfizer’s credibility among conservatives is in tatters. No amount of political maneuvering can erase the deep skepticism that remains. Bourla may have been invited to the event, but the message from the crowd was unmistakable—Pfizer is no friend of the America First movement.
